Table 2

Comparison of cancer screening among cancer survivors and controls: Proportion never screened during the 4-year study period.

SCREENING MANEUVERS
CANCER SURVIVORS AND CONTROLSBREAST CANCER SCREENING*CRC SCREENING†CERVICAL CANCER SCREENING‡PERIODIC HEALTH EXAMINATION
Breast cancerNA
  • Cases, N653072611 219
  • Controls, N32 51734 22856 014
  • Never screened
     - Cases, n (%)4262 (65.3)2673 (39.7)3770 (33.6)
     - Controls, n (%)22 025 (67.7)16 639 (48.6)21 381 (38.2)
  • OR (95% CI)1.12§ (1.06–1.18)1.48§ (1.40–1.56)1.23§ (1.18–1.28)
CRCNA
  • Cases, N148910714348
  • Controls, N7441552721 740
  • Never screened
     - Cases, n (%)691 (46.4)574 (53.6)2028 (46.6)
     - Controls, n (%)3123 (42.0)2883 (52.2)8244 (37.9)
  • OR (95% CI)0.83|| (0.74–0.93)0.94 (0.82–1.08)0.69§ (0.65–0.74)
Endometrial cancerNA
  • Cases, N271324523473
  • Controls, N13 99312 28117 357
  • Never screened
     - Cases, n (%)872 (32.1)1608 (65.6)1358 (39.1)
     - Controls, n (%)5900 (42.2)8447 (68.8)6699 (38.6)
  • OR (95% CI)1.60§ (1.46–1.75)1.16|| (1.06–1.27)0.98 (0.91–1.06)
HL
  • Cases, N1513626052071
  • Controls, N7621835302510 229
  • Never screened
     - Cases, n (%)66 (43.7)279 (77.1)196 (32.4)902 (43.6)
     - Controls, n (%)307 (40.3)1306 (71.2)968 (32.0)4195 (41.0)
  • OR (95% CI)0.86 (0.60–1.25)0.73 (0.56–0.96)0.98 (0.80–1.19)0.89 (0.81–0.99)

  • CRC—colorectal cancer, HL—Hodgkin lymphoma, OR—odds ratio, NA—not applicable.

  • ↵* Among subjects aged 50 to 79 y.

  • ↵† Among subjects aged 50 to 74 y.

  • ↵‡ Among subjects aged 20 to 69 y.

  • ↵§ P < .0001.

  • ↵|| P < .005.

  • ↵ P = .02.